TBI Biomarker
Device
Abbott Laboratories
Total Payments
$101,000
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $61,000 | 3 | 0 |
| 2018 | $40,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $101,000 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| De novo discovery of potential circulating TBI biomarkers in serum or plasma | Abbott Laboratories | $80,000 | 0 |
| Transforming Research and Clinical Knowledge in Traumatic Brain Injury TRACK TBI | Abbott Laboratories | $21,000 | 0 |
Top Doctors Receiving Payments for TBI Biomarker
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $101,000 | 4 |
Ad
Manufacturing Companies
- Abbott Laboratories $101,000
Product Information
- Type Device
- Total Payments $101,000
- Total Doctors 0
- Transactions 4
About TBI Biomarker
TBI Biomarker is a device associated with $101,000 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2019. In 2019, $61,000 was paid across 3 transactions to 0 doctors.
The most common payment nature for TBI Biomarker is "Unspecified" ($101,000, 100.0% of total).
TBI Biomarker is associated with 2 research studies, including "De novo discovery of potential circulating TBI biomarkers in serum or plasma" ($80,000).